*By Bridgette Webb*
Drugmaker Merck announced earlier this month it will slash prices on several drugs by 10 percent or more.
But there is a catch: the price rollback will only affect some of the smaller products in its portfolioーlike Hepatitis C drug, Zepatier, which accounts for about 4 percent of the company's salesーand not top sellers like cancer treatment Keytruda.
"Their scope is relatively limited," said Peter Loftus, a Reporter for the Wall Street Journal, during an interview on Cheddar Monday. "If you think about the total sales that Merck generatesーit's a relatively small percentage."
Merck's announcement was met with praise from the Trump administration. Health and Human Services Secretary Alex Azar claimed the drop in prices was spurred by Trump's latest crackdown on pharmaceutical companies.
Other big pharma names are following suit: Pfizer and Novartis announced they will freeze price increases for the rest of the year, earning them congratulatory tweets from the president.
Despite all of the price freezes and drops, Loftus says that patients may not actually see any real savings.
"I don't think you can say on a widespread basis, and really for the average drug or patient, that prices are coming down, there are still price increases."
For the full segment, [click here.]
(https://cheddar.com/videos/drugmakers-tout-lower-prices)
The ongoing Avian flu, popularly referred to as the bird flu, is ravaging bird communities and is even crossing over into other mammal populations.
The life-saving overdose reversal agent Narcan is one step closer to being easily accessed by the general public.
Once COVID-19 hit, the demand for mental health services skyrocketed, and with in-person care suspended, many turned to digital services — which led to a disturbing breach of data privacy.
Quaoar, a dwarf planet with a ring, has some astronomers scratching their heads over its much wider than expected ring system.
More details are emerging out of East Palestine, Ohio with officials discovering three additional chemicals following the Norfolk Southern train derailment and controlled burn of hazardous materials.
An Obama-era change to school lunches could be linked to a drop in childhood obesity rates, a new study suggests.
Teen girls are experiencing record levels of sadness, according to a report from the CDC.
A study by the Pew Research Center found that three in 10 Americans are single and nearly half of them are turning to dating apps to find companionship.
Seonghoon Woo, CEO of Amogy, joined Cheddar News to discuss its ammonia-powered, zero-emission semi-truck in an effort to de-carbonize transportation.
NASA is launching a scientific mission to Mars using Blue Origin's New Glenn rocket.
